<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001783244</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001040470</issuerCik>
      <issuerName>AEHR TEST SYSTEMS</issuerName>
      <secFileNumber>000-22893</secFileNumber>
      <issuerAddress>
        <com:street1>400 KATO TERRACE</com:street1>
        <com:city>FREMONT</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94539</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>5106239400</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>OLIPHANT LAURA</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab Corp.</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>1008</noOfUnitsSold>
      <aggregateMarketValue>52214.00</aggregateMarketValue>
      <noOfUnitsOutstanding>28338209</noOfUnitsOutstanding>
      <approxSaleDate>07/31/2023</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>04/19/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Equity Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>504</amountOfSecuritiesAcquired>
      <paymentDate>04/19/2022</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>07/19/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Equity Compensation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>504</amountOfSecuritiesAcquired>
      <paymentDate>07/19/2022</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>07/31/2023</noticeDate>
      <signature>Laura A Oliphant</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3235}]
144
0001783244
XXXXXXXX
LIVE
0001040470
AEHR TEST SYSTEMS
000-22893
400 KATO TERRACE
FREMONT
CA
94539
5106239400
OLIPHANT LAURA
Officer
Common
Charles Schwab Corp.
3000 Schwab Way
Westlake
TX
76262
1008
52214.00
28338209
07/31/2023
Nasdaq
Common
04/19/2022
Equity Compensation
Issuer
N
504
04/19/2022
Equity Compensation
Common
07/19/2022
Equity Compensation
Issuer
N
504
07/19/2022
Equity Compensation
Y
07/31/2023
Laura A Oliphant